Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ANPCYNASDAQ:BIAFWOTCMKTS:EPGNYOTCMKTS:WUXAY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANPCYANGLEC$0.79-24.8%C$1.11C$0.74▼C$3.35N/AN/A1,257 shs1,094 shsBIAFWbioAffinity Technologies$0.16-4.7%$0.22$0.12▼$2.90N/AN/A8,540 shs174 shsEPGNYEpigenomics$2.39$2.39$2.01▼$2.39N/AN/A100 shsN/AWUXAYWuXi AppTec$7.80+3.3%$7.75$3.50▼$9.40N/AN/A8,162 shs61,894 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANPCYANGLE-24.76%-20.30%-28.51%-57.22%-67.08%BIAFWbioAffinity Technologies0.00%+11.64%-14.21%-43.99%-58.21%EPGNYEpigenomics0.00%0.00%0.00%0.00%0.00%WUXAYWuXi AppTec+3.31%+0.78%+29.72%+3.89%+65.80%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANPCYANGLEN/AN/AN/AN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANPCYANGLE 0.00N/AN/AN/ABIAFWbioAffinity Technologies 0.00N/AN/AN/AEPGNYEpigenomics 0.00N/AN/AN/AWUXAYWuXi AppTec 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANPCYANGLEN/AN/AN/AN/AN/AN/ABIAFWbioAffinity Technologies$9.36MN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANPCYANGLEN/A-C$0.48N/A∞N/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/AEPGNYEpigenomicsN/A-$3.05N/A∞N/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANPCYANGLEN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/AEPGNYEpigenomicsN/AWUXAYWuXi AppTecN/AInsider OwnershipCompanyInsider OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/AEPGNYEpigenomicsN/AWUXAYWuXi AppTecN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANPCYANGLE173N/AN/ANot OptionableBIAFWbioAffinity Technologies10N/AN/ANot OptionableEPGNYEpigenomics32N/AN/ANot OptionableWUXAYWuXi AppTec41,116N/AN/ANot OptionableWUXAY, ANPCY, BIAFW, and EPGNY HeadlinesRecent News About These CompaniesWuXi AppTec Co., (WUXIF) Ltd. Q1 2025 Earnings Call TranscriptApril 29, 2025 | seekingalpha.comMendota Heights med tech company to lay off 124 workers after acquisitionApril 8, 2025 | twincities.comWuXi AppTec's Changzhou and Taixing API Sites Successfully Pass FDA InspectionsMarch 31, 2025 | finance.yahoo.comWuXi AppTec Proposes 2025 H Share Award Scheme to Enhance Talent RetentionMarch 17, 2025 | tipranks.comWuXi AppTec Schedules Board Meeting to Discuss 2024 Financial ResultsMarch 3, 2025 | tipranks.comWuXi AppTec Updates Board Composition for Strategic GovernanceJanuary 22, 2025 | tipranks.comWuXi moves ahead with new $510M campus in Delaware despite sale of Navy Yard operationsJanuary 21, 2025 | bizjournals.comWuXi AppTec sells medical device testing unit; Layoffs at Notch TherapeuticsJanuary 17, 2025 | endpts.comWuXi AppTec sells US medical device testing business to NAMSAJanuary 17, 2025 | fiercebiotech.comNAMSA acquires WuXi AppTec’s US medical device testing facilitiesJanuary 17, 2025 | finance.yahoo.comWuXi AppTec Disposes Shares to Bolster Global ExpansionJanuary 13, 2025 | tipranks.comChina’s WuXi Biologics to sell vaccine facility to Merck for US$500 millionJanuary 7, 2025 | businesstimes.com.sgWuXi Biologics to sell Ireland-based vaccine site to MSD for $500mJanuary 7, 2025 | finance.yahoo.comWuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 MillionJanuary 7, 2025 | msn.comWuXi AppTec deal eases pressure from Congress on Penn and CHOP biotechJanuary 7, 2025 | msn.comChina's WuXi Biologics to sell Irish vaccine facility to Merck for €500mJanuary 6, 2025 | laois-nationalist.ieChina's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loomJanuary 6, 2025 | msn.comWuxi AppTec Selling Cell, Gene Therapy Unit to AltarisDecember 30, 2024 | precisionmedicineonline.comWuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive YearDecember 30, 2024 | finance.yahoo.comdear lottery draw todayDecember 30, 2024 | bweducation.businessworld.inMedia Sentiment Over TimeWUXAY, ANPCY, BIAFW, and EPGNY Company DescriptionsANGLE OTCMKTS:ANPCYC$0.79 -0.26 (-24.76%) As of 05/8/2025 03:58 PM EasternANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.bioAffinity Technologies NASDAQ:BIAFW$0.16 -0.01 (-4.73%) As of 05/8/2025 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.Epigenomics OTCMKTS:EPGNY$2.39 0.00 (0.00%) As of 04/6/2023Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.WuXi AppTec OTCMKTS:WUXAY$7.80 +0.25 (+3.31%) As of 05/8/2025 03:52 PM EasternWuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Energy Transfer Undervalued or a Value Trap? Carvana’s Stock Price Rebound Shifts Into a Higher Gear Why Investors Should Be Careful About AMC's Bitcoin Dreams Alphabet Slumps as Apple Eyes AI Search—Is the Sell-Off Overdone? Joby's Q1: Key Milestones Achieved as Path to Market Crystalizes Rockwell Automation: Tailwinds From Onshoring U.S. Production IBM's AI Offensive: Assessing IBM's Path to Renewed Growth Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
